Evidence map›Paper›PMID 23493550›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition.

Crina Paduraru, Jelena S Bezbradica, Amit Kunte, Robert Kelly, James A Shayman, Natacha Veerapen, Liam R Cox, Gurdyal S Besra, Peter Cresswell

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Updating Phospholipase ABiomolecules · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. From Lysosomal Storage Diseases to NKT Cell Activation and Back.International journal of molecular sciences · 2017
    Review
  11. Lipoquality control by phospholipase AProceedings of the Japan Academy. Series B, Physical and biological sciences · 2017
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Bee venom processes human skin lipids for presentation by CD1a.The Journal of experimental medicine · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Crina PaduraruDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520-8011, USA.
Jelena S Bezbradica
Amit Kunte
Robert Kelly
James A Shayman
Natacha Veerapen
Liam R Cox
Gurdyal S Besra
Peter Cresswell
Howard Hughes Medical Institute · USUniversity of Michigan–Ann Arbor · USUniversity of Birmingham · GBYale University · US

Funding

Molecular Aspects of Human CD1d FunctionsR01AI059167 · NIAID · YALE UNIVERSITY · PI CRESSWELL, PETER · 2004 to 2019
$5.6M
Lysosomal Phospholipase A2 in Autoimmune DiseaseR01AR056991 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAYMAN, JAMES ALAN · 2010 to 2014
$1.6M
Howard Hughes Medical InstituteMedical Research Council G1001750NIAID NIH HHS R01 AI059167NIAID NIH HHS R01-AI059167NIAMS NIH HHS 5R01-AR056991NIAMS NIH HHS R01 AR056991Wellcome Trust 084923/B/08/Z
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells recognize self lipid antigens presented by CD1d molecules. The nature of the self-antigens involved in the development and maturation of iNKT cells is poorly defined. Lysophospholipids are self-antigens presented by CD1d that are generated through the action of phospholipases A1 and A2. Lysosomal phospholipase A2 (LPLA2, group XV phospholipase A2) resides in the endocytic system, the main site where CD1d antigen acquisition occurs, suggesting that it could be particularly important in CD1d function. We find that Lpla2(-/-) mice show a decrease in iNKT cell numbers that is neither the result of a general effect on the development of lymphocyte populations nor of effects on CD1d expression. However, endogenous lipid antigen presentation by CD1d is reduced in the absence of LPLA2. Our data suggest that LPLA2 plays a role in the generation of CD1d complexes with thymic lipids required for the normal selection and maturation of iNKT cells.

Indexed as

AcyltransferasesAnimalsAntigen PresentationAntigensAntigens, CD1dLymphocyte CountLysosomesMiceMice, KnockoutNatural Killer T-CellsPhospholipases A2Thymus GlandAcyltransferasesAntigensAntigens, CD1dCd1d1 protein, mousephospholipase A2, group XVPhospholipases A2

Identifiers

PMID23493550
PMCPMC3612615
OpenAlexW2010183239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.